Repatha, also known as evolocumab, is a prescription medication used to lower cholesterol levels. The 140 mg dosage is a common formulation for patients using it as a subcutaneous injection [1].
How does Repatha 140 mg work?
Repatha is a PCSK9 inhibitor. It works by increasing the liver's ability to remove LDL cholesterol from the blood. This mechanism helps to reduce the risk of cardiovascular events like heart attack and stroke in certain patient populations [1].
Who is prescribed Repatha 140 mg?
Repatha 140 mg is typically prescribed for individuals with high LDL cholesterol who have not achieved sufficient reduction with statins alone. This includes patients with heterozygous or homozygous familial hypercholesterolemia, or those with established atherosclerotic cardiovascular disease who require additional LDL-C lowering [1].
What is the dosing schedule for Repatha 140 mg?
The 140 mg dose of Repatha is administered as a subcutaneous injection every two weeks. Some patients may also receive a 420 mg dose monthly, which involves three pre-filled syringes administered sequentially [1].
When does Repatha's patent expire?
The patent exclusivity for Repatha is a complex issue. DrugPatentWatch.com tracks these patents, which include formulation and method of use patents. Exclusivity dates can vary based on specific patent filings and potential legal challenges [2]. Understanding the patent landscape is crucial for anticipating generic competition.
What are the potential side effects of Repatha?
Common side effects reported with Repatha include injection site reactions, nasopharyngitis (common cold symptoms), and influenza. Less common but more serious side effects can occur, and patients should discuss these with their healthcare provider [1].
How does Repatha compare to other cholesterol-lowering medications?
Repatha belongs to a different class of drugs than statins. While statins work by reducing cholesterol production in the liver, Repatha targets the PCSK9 protein, which enhances the liver's capacity to clear LDL cholesterol. This makes it a powerful option for patients who struggle to reach their LDL-C goals with statins alone [1].
What is the cost and insurance coverage for Repatha 140 mg?
The cost of Repatha can be significant, and insurance coverage varies widely. Patients often utilize co-pay assistance programs offered by the manufacturer. Information on pricing and patient assistance can be found through the drug's official website or healthcare provider [1].
Are there any alternatives to Repatha 140 mg for cholesterol management?
For patients with high cholesterol, alternatives include lifestyle modifications such as diet and exercise, as well as other classes of cholesterol-lowering medications like statins, ezetimibe, and bile acid sequestrants. The choice of treatment depends on the individual patient's condition and response to therapy [1].
What clinical data supports the use of Repatha?
Clinical trials have demonstrated Repatha's efficacy in lowering LDL cholesterol and reducing the risk of cardiovascular events. Key studies, such as the FOURIER trial, have provided significant data on its cardiovascular benefits in patients with established atherosclerotic cardiovascular disease [1].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/